News on research and diagnostics in autoimmune disorders including rheumatoid arthritis, lupus, multiple sclerosis, and more.
The partners will conduct an exploratory study to determine how the results of Exagen's lupus test impacts primary care physician practice referral patterns.
The firm aims to integrate protein biomarker measurements, data from patient wearables, and imaging to improve treatment and management of multiple sclerosis.
The Phadia 200 quantifies clinically relevant antibodies in blood and can perform up to 700 different ImmunoCAP and EliA tests.
The immunofluorescence assays support the detection of anti-double-stranded DNA, which is a marker for systemic lupus erythematosus.
The assay can be used in conjunction with other laboratory and clinical findings to differentiate IBD from irritable bowel syndrome, the firm said.
